BioCentury
ARTICLE | Financial News

Teva financial update

February 16, 2015 8:00 AM UTC

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Date announced: 2015-02-12 Note: Teva began a tender offer to acquire up to $1 billion...